These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 9973200

  • 1. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ, Li Y, Xiong Y, Guan KL.
    Cancer Res; 1999 Feb 01; 59(3):558-64. PubMed ID: 9973200
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 3. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J, Byeon IJ, Ericson K, Poi MJ, O'Maille P, Selby T, Tsai MD.
    Biochemistry; 1999 Mar 09; 38(10):2930-40. PubMed ID: 10074345
    [Abstract] [Full Text] [Related]

  • 4. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
    Shimizu T, Awai N, Takeda K.
    Oncogene; 2000 Sep 21; 19(40):4640-6. PubMed ID: 11030153
    [Abstract] [Full Text] [Related]

  • 5. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.
    Cell Growth Differ; 1996 Feb 21; 7(2):135-46. PubMed ID: 8822197
    [Abstract] [Full Text] [Related]

  • 6. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4.
    Li J, Poi MJ, Qin D, Selby TL, Byeon IJ, Tsai MD.
    Biochemistry; 2000 Feb 01; 39(4):649-57. PubMed ID: 10651629
    [Abstract] [Full Text] [Related]

  • 7. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
    Timmermann S, Hinds PW, Münger K.
    Cell Growth Differ; 1997 Apr 01; 8(4):361-70. PubMed ID: 9101082
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 01; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M, Liu E, Xiong Y.
    Oncogene; 1996 Jan 18; 12(2):451-5. PubMed ID: 8570224
    [Abstract] [Full Text] [Related]

  • 10. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J, Wei T, Lahti JM, Kidd VJ.
    Cancer Res; 1998 Jun 15; 58(12):2624-32. PubMed ID: 9635589
    [Abstract] [Full Text] [Related]

  • 11. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
    Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ.
    Mol Cell Biol; 1995 May 15; 15(5):2672-81. PubMed ID: 7739547
    [Abstract] [Full Text] [Related]

  • 12. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
    Franklin DS, Xiong Y.
    Mol Biol Cell; 1996 Oct 15; 7(10):1587-99. PubMed ID: 8898364
    [Abstract] [Full Text] [Related]

  • 13. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y.
    Genes Dev; 1994 Dec 15; 8(24):2939-52. PubMed ID: 8001816
    [Abstract] [Full Text] [Related]

  • 14. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 15; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 15. A p18 mutant defective in CDK6 binding in human breast cancer cells.
    Lapointe J, Lachance Y, Labrie Y, Labrie C.
    Cancer Res; 1996 Oct 15; 56(20):4586-9. PubMed ID: 8840966
    [Abstract] [Full Text] [Related]

  • 16. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD, Tong L, Pavletich NP.
    Genes Dev; 2000 Dec 15; 14(24):3115-25. PubMed ID: 11124804
    [Abstract] [Full Text] [Related]

  • 17. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T, Narita T, Uchida-Toita M, Yoshida M.
    Virology; 1999 Jul 05; 259(2):384-91. PubMed ID: 10388662
    [Abstract] [Full Text] [Related]

  • 19. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M, Bartkova J, Khan S, Hansen K, Rönnstrand L, Lukas J, Strauss M, Bartek J.
    FEBS Lett; 2000 Mar 24; 470(2):161-6. PubMed ID: 10734227
    [Abstract] [Full Text] [Related]

  • 20. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC.
    Nat Genet; 1995 May 24; 10(1):114-6. PubMed ID: 7647780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.